CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1/2, Open Label, Multicenter Study to Assess the Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory CD20+ B-Cell Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05360238
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:22.087665+00:00
Published At: 2024-07-22T00:00:00+00:00
Record Updated At: 2024-07-22
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Follicular B-cell Non-Hodgkin\u0027s Lymphoma", "Mantle Cell Lymphoma Recurrent", "Mantle Cell Lymphoma Refractory", "Small Lymphocytic Lymphoma, Relapsed", "Waldenstrom\u0027s Macroglobulinemia Recurrent", "Waldenstrom\u0027s Macroglobulinemia Refractory", "Chronic Lymphoid Leukemia in Relapse", "B-cell Lymphoma Refractory"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-07-22"
protocolSection.identificationModule.nctId: "NCT05360238"
protocolSection.identificationModule.officialTitle: "A Phase 1/2, Open Label, Multicenter Study to Assess the Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory CD20+ B-Cell Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.